Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
Archives of Hepatitis Research
Review Article
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of fatty liver, characterized by the accumulation of fat in the hepatocytes in the absence of alcohol consumption. The spectrum of this disease ranges from steatosis to hepatitis and fi nally cirrhosis and hepatocellular carcinoma.
https://www.peertechz.com/articles/farnesoid-x-receptor-agonist-as-a-new-treatment-option-for-non-alcoholic-fatty-liver-disease-a-review.pdf
Review Article
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of fatty liver, characterized by the accumulation of fat in the hepatocytes in the absence of alcohol consumption. The spectrum of this disease ranges from steatosis to hepatitis and fi nally cirrhosis and hepatocellular carcinoma.
https://www.peertechz.com/articles/farnesoid-x-receptor-agonist-as-a-new-treatment-option-for-non-alcoholic-fatty-liver-disease-a-review.pdf
Comments
Post a Comment